219 related articles for article (PubMed ID: 33708358)
1. Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.
Mao X; Zhou L; Tey SK; Ma APY; Yeung CLS; Ng TH; Wong SWK; Liu BHM; Fung YME; Patz EF; Cao P; Gao Y; Yam JWP
J Extracell Vesicles; 2020 Nov; 10(1):e12031. PubMed ID: 33708358
[TBL] [Abstract][Full Text] [Related]
2. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
Tey SK; Wong SWK; Chan JYT; Mao X; Ng TH; Yeung CLS; Leung Z; Fung HL; Tang AHN; Wong DKH; Mak LY; Yuen MF; Sin CF; Ng IO; Ma SKY; Lee TKW; Cao P; Zhong K; Gao Y; Yun JP; Yam JWP
J Hepatol; 2022 Apr; 76(4):883-895. PubMed ID: 34922977
[TBL] [Abstract][Full Text] [Related]
3. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.
Yang Y; Mao F; Guo L; Shi J; Wu M; Cheng S; Guo W
Dig Liver Dis; 2021 Apr; 53(4):474-485. PubMed ID: 33563583
[TBL] [Abstract][Full Text] [Related]
4. Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis.
Bushey RT; Gottlin EB; Campa MJ; Patz EF
PLoS One; 2021; 16(6):e0252577. PubMed ID: 34133431
[TBL] [Abstract][Full Text] [Related]
5. Actin-related protein 2/3 complex subunit 2-enriched extracellular vesicles drive liver cancer metastasis.
Mei P; Tey SK; Wong SWK; Ng TH; Mao X; Yeung CLS; Xu Y; Yu L; Huang Q; Cao P; Yam JWP; Gao Y
Hepatol Int; 2022 Jun; 16(3):603-613. PubMed ID: 35556226
[TBL] [Abstract][Full Text] [Related]
6. TPI1-reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis.
Liu BHM; Tey SK; Mao X; Ma APY; Yeung CLS; Wong SWK; Ng TH; Xu Y; Yao Y; Fung EYM; Tan KV; Khong PL; Ho DW; Ng IO; Tang AHN; Cai SH; Yun JP; Yam JWP
J Extracell Vesicles; 2021 Aug; 10(10):e12135. PubMed ID: 34401050
[TBL] [Abstract][Full Text] [Related]
7. S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos.
Wang X; Huang H; Sze KM; Wang J; Tian L; Lu J; Tsui YM; Ma HT; Lee E; Chen A; Lee J; Wang Y; Yam JWP; Cheung TT; Guan X; Ng IO
Gut; 2023 Jul; 72(7):1370-1384. PubMed ID: 36631249
[TBL] [Abstract][Full Text] [Related]
8. Complement factor H-deficient mice develop spontaneous hepatic tumors.
Laskowski J; Renner B; Pickering MC; Serkova NJ; Smith-Jones PM; Clambey ET; Nemenoff RA; Thurman JM
J Clin Invest; 2020 Aug; 130(8):4039-4054. PubMed ID: 32369457
[TBL] [Abstract][Full Text] [Related]
9. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2.
Zhou J; Che J; Xu L; Yang W; Zhou W; Zhou C
Dig Liver Dis; 2022 Apr; 54(4):543-553. PubMed ID: 34497040
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma cell-derived extracellular vesicles encapsulated microRNA-584-5p facilitates angiogenesis through PCK1-mediated nuclear factor E2-related factor 2 signaling pathway.
Shao Z; Pan Q; Zhang Y
Int J Biochem Cell Biol; 2020 Aug; 125():105789. PubMed ID: 32522621
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer.
Chen C; Zheng H; Luo Y; Kong Y; An M; Li Y; He W; Gao B; Zhao Y; Huang H; Huang J; Lin T
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33661764
[TBL] [Abstract][Full Text] [Related]
14. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
Duan F; Wu H; Jia D; Wu W; Ren S; Wang L; Song S; Guo X; Liu F; Ruan Y; Gu J
J Hepatol; 2018 Jun; 68(6):1191-1202. PubMed ID: 29454068
[TBL] [Abstract][Full Text] [Related]
17. SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.
Lv X; Yu H; Zhang Q; Huang Q; Hong X; Yu T; Lan H; Mei C; Zhang W; Luo H; Pang P; Shan H
J Cell Mol Med; 2020 Sep; 24(18):10714-10729. PubMed ID: 32746503
[TBL] [Abstract][Full Text] [Related]
18. CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis.
Wang F; Zhao W; Gao Y; Zhou J; Li H; Zhang G; Guo D; Xie C; Li J; Yin Z; Zhang J
J Exp Clin Cancer Res; 2019 Jul; 38(1):286. PubMed ID: 31272499
[TBL] [Abstract][Full Text] [Related]
19. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma.
Zhang K; Dong C; Chen M; Yang T; Wang X; Gao Y; Wang L; Wen Y; Chen G; Wang X; Yu X; Zhang Y; Wang P; Shang M; Han K; Zhou Y
Theranostics; 2020; 10(1):411-425. PubMed ID: 31903129
[No Abstract] [Full Text] [Related]
[Next] [New Search]